http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020038399-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8be09ab5797d1efd0dbf7c48d7cbb9ab |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-50 |
| filingDate | 2000-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_708c240690235a98ebe44c75eacd3062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ac46bd2db9806b3d65e367d212a9534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83b9d5f279db8d874f89c314dadaec99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d274dce56715a3af5b741bfe1deb5dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f8329f4563caa77d9cecd09ec8b3e91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e09201a98165b77fac6c0b2219b3bd07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a1533400188059869a04e9701f4d0ba |
| publicationDate | 2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20020038399-A |
| titleOfInvention | Ring-peptide compounds having lactam bond acting to melanocortin receptors |
| abstract | The present invention relates to a cyclic peptide-type compound consisting of a lactam bond acting on the melanocortin receptor, comprising a cyclic peptide-type compound consisting of a lactam bond of the present invention represented by the structure of the following formula (1) or (2) It relates to a composition.n n n The cyclic peptide-type compound consisting of lactam bonds of the present invention and a composition comprising the same as an active ingredient act as an anti-inflammatory agent or antagonist to the melanocortin receptor, and according to the type of the receptor, a cosmetic composition for skin whitening or tanning, for external treatment of skin It is effective in the prevention and treatment of MCR hyperactivity and hypoplasia-related diseases, such as compositions, and compositions for treating inflammation, erectile dysfunction, diabetes, morbid appetite, obesity, and withdrawal symptoms after opioid poisoning.n n n [Formula 1]n n n n n n n n In Formula 1, a is 0 or 1, E 1 , E 2 , E 3 , E 4 , E 5 are each an amino acid or a derivative thereof, and the amine group of E 1 forms a peptide bond with a carboxyl group of E 5 It forms a peptide. |
| priorityDate | 2000-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.